IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAVAZZANA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.757
EU - Europa 7.751
AS - Asia 5.641
SA - Sud America 1.048
Continente sconosciuto - Info sul continente non disponibili 315
AF - Africa 136
OC - Oceania 10
Totale 26.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.502
IT - Italia 4.238
SG - Singapore 1.958
CN - Cina 1.837
UA - Ucraina 930
BR - Brasile 867
DE - Germania 643
HK - Hong Kong 544
FR - Francia 402
VN - Vietnam 378
FI - Finlandia 328
GB - Regno Unito 315
BD - Bangladesh 284
IE - Irlanda 229
RU - Federazione Russa 224
TR - Turchia 189
IN - India 153
CA - Canada 125
NL - Olanda 78
AR - Argentina 69
SE - Svezia 59
MX - Messico 56
IQ - Iraq 48
ES - Italia 46
ZA - Sudafrica 46
AT - Austria 42
JP - Giappone 36
PL - Polonia 35
BE - Belgio 29
PK - Pakistan 28
EC - Ecuador 26
ID - Indonesia 25
EE - Estonia 24
CO - Colombia 22
RO - Romania 21
LT - Lituania 20
MA - Marocco 20
VE - Venezuela 20
JM - Giamaica 18
AE - Emirati Arabi Uniti 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
KE - Kenya 15
NG - Nigeria 15
IL - Israele 14
JO - Giordania 14
CH - Svizzera 12
EG - Egitto 12
KZ - Kazakistan 11
PY - Paraguay 11
TT - Trinidad e Tobago 11
CZ - Repubblica Ceca 10
AU - Australia 9
CR - Costa Rica 9
EU - Europa 9
PE - Perù 9
PH - Filippine 9
AZ - Azerbaigian 8
CL - Cile 8
HN - Honduras 8
TH - Thailandia 8
UY - Uruguay 8
DZ - Algeria 7
MK - Macedonia 7
KG - Kirghizistan 6
LU - Lussemburgo 6
PA - Panama 6
BO - Bolivia 5
DK - Danimarca 5
IR - Iran 5
LV - Lettonia 5
NO - Norvegia 5
NP - Nepal 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
GR - Grecia 4
HU - Ungheria 4
AO - Angola 3
BB - Barbados 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LI - Liechtenstein 3
MU - Mauritius 3
MY - Malesia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BM - Bermuda 2
CI - Costa d'Avorio 2
ET - Etiopia 2
Totale 26.315
Salva come PNG Salva come JPEG
Città #
Fairfield 1.061
Singapore 1.009
Ashburn 938
Woodbridge 800
Jacksonville 682
Houston 586
San Jose 579
Hong Kong 542
Beijing 448
Seattle 426
Cambridge 418
Wilmington 416
The Dalles 401
Ann Arbor 377
Milan 347
New York 314
Princeton 311
Los Angeles 294
Chandler 280
Council Bluffs 234
Chicago 232
Rome 232
Nanjing 224
Helsinki 204
Dublin 167
Lauterbourg 157
Istanbul 150
Columbus 144
Brescia 137
Dallas 136
Ho Chi Minh City 136
Florence 113
Buffalo 108
Munich 91
Des Moines 89
Moscow 88
Nanchang 84
Salt Lake City 82
São Paulo 72
Santa Clara 70
Hanoi 69
San Diego 68
San Francisco 66
Turin 65
Hebei 64
Redondo Beach 64
Trieste 61
Shenyang 60
Bologna 59
Lancaster 57
Verona 56
Changsha 55
Shanghai 51
London 50
Tianjin 50
Jinan 44
Phoenix 44
Genoa 41
Jiaxing 39
Orem 38
Brooklyn 36
Tampa 36
Dearborn 35
Toronto 35
Elk Grove Village 34
Nuremberg 34
Tokyo 34
Udine 34
Frankfurt am Main 33
Padova 32
Naples 30
Turku 30
Atlanta 28
Rio de Janeiro 28
Brussels 27
Bergamo 25
Chennai 25
Kunming 25
Montreal 25
Mumbai 25
Pisa 25
Genova 24
Tallinn 24
Johannesburg 23
Modena 23
Belo Horizonte 22
Miami 22
Palermo 22
Warsaw 22
Hangzhou 21
Syracuse 21
Vienna 21
Amsterdam 20
Guangzhou 20
Menlo Park 20
Falkenstein 19
Baghdad 18
Charlotte 18
Manchester 18
Mexico City 18
Totale 15.312
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.396
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.863
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 710
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 248
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 225
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 224
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 222
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 220
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 197
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 195
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 191
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 189
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 186
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 183
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 182
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 180
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 179
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 178
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 177
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 176
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 172
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 172
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 169
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 166
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 166
The clinico-serological spectrum of overlap myositis 161
Autoimmune polyendocrine Syndromes 158
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 158
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 158
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 158
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 157
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 157
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 155
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 154
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 151
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 149
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 148
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 148
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 145
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 145
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 144
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 144
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 144
Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? 143
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 142
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 142
Anti-Ro/SSA and La/SSB antibodies 142
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 142
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 141
Endothelium and the brain in CNS lupus. 140
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 138
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 137
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 136
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 134
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 134
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 134
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 133
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 132
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 132
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 132
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 130
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 130
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 130
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 129
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 128
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 128
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 127
Complement Activation and Pregnancy Failure. 125
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 125
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 125
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 124
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 124
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 123
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 123
Serologic profile and mortality rates of scleroderma renal crisis in Italy 123
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 122
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 122
Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. 121
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 121
Cardiological features in idiopathic inflammatory myopathies. 121
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 120
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 120
Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations 120
Update on Antiphospholipid Syndrome: Ten Topics in 2017 120
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 119
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 119
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 118
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 118
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 118
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 118
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 118
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 118
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 118
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 117
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 116
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 116
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 115
Value Of Diastolic Dysfunction In Asymptomatic Rheumatoid Arthritis Patients Without Cardiovascular Risk Factors 115
Comparison of early and late onset systemic lupus erythematosus 114
Totale 19.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.636 0 0 112 106 116 147 151 154 135 195 180 340
2022/20231.482 207 26 45 64 115 331 36 164 257 50 102 85
2023/20241.543 81 52 120 121 86 278 82 68 330 58 62 205
2024/20254.119 70 75 59 366 368 358 262 159 354 317 853 878
2025/20267.013 632 976 510 925 631 486 1.049 267 401 541 353 242
2026/20271.046 369 396 281 0 0 0 0 0 0 0 0 0
Totale 26.658